BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37873473)

  • 1. The G1/S transition is promoted by Rb degradation via the E3 ligase UBR5.
    Zhang S; Valenzuela LF; Zatulovskiy E; Mangiante L; Curtis C; Skotheim JM
    bioRxiv; 2024 Apr; ():. PubMed ID: 37873473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix.
    Topacio BR; Zatulovskiy E; Cristea S; Xie S; Tambo CS; Rubin SM; Sage J; Kõivomägi M; Skotheim JM
    Mol Cell; 2019 May; 74(4):758-770.e4. PubMed ID: 30982746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D activates the Rb tumor suppressor by mono-phosphorylation.
    Narasimha AM; Kaulich M; Shapiro GS; Choi YJ; Sicinski P; Dowdy SF
    Elife; 2014 Jun; 3():. PubMed ID: 24876129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin Y binds and activates CDK4 to promote the G1/S phase transition in hepatocellular carcinoma cells via Rb signaling.
    Chen L; Wang X; Cheng H; Zhang W; Liu Y; Zeng W; Yu L; Huang C; Liu G
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1162-1169. PubMed ID: 33039146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
    Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
    J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Retinoblastoma Protein (RB) E3 Ubiquitin Ligase (NRBE3) Promotes RB Degradation and Is Transcriptionally Regulated by E2F1 Transcription Factor.
    Wang Y; Zheng Z; Zhang J; Wang Y; Kong R; Liu J; Zhang Y; Deng H; Du X; Ke Y
    J Biol Chem; 2015 Nov; 290(47):28200-28213. PubMed ID: 26442585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition.
    Kaulich M; Link VM; Lapek JD; Lee YJ; Glass CK; Gonzalez DJ; Dowdy SF
    Sci Rep; 2021 Jul; 11(1):14736. PubMed ID: 34282211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
    Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Diehl JA; Zindy F; Sherr CJ
    Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
    Gaben AM; Saucier C; Bedin M; Barbu V; Mester J
    Int J Cancer; 2004 Jan; 108(2):200-6. PubMed ID: 14639603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
    Leng X; Connell-Crowley L; Goodrich D; Harper JW
    Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dibutyryl cyclic AMP enhances the down-regulation of RB protein during G1 phase in the proliferating primary rat hepatocytes, but inhibits their entries into S phase and RB's phosphorylation.
    Okamoto Y; Kikuchi E; Matsumoto M; Nakano H
    Biochem Biophys Res Commun; 1993 Aug; 195(1):84-9. PubMed ID: 8395839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active RB elicits late G1/S inhibition.
    Angus SP; Fribourg AF; Markey MP; Williams SL; Horn HF; DeGregori J; Kowalik TF; Fukasawa K; Knudsen ES
    Exp Cell Res; 2002 Jun; 276(2):201-13. PubMed ID: 12027450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of p27 (Kip1) by Ubiquitin E3 Ligase RNF6.
    Deshmukh D; Xu J; Yang X; Shimelis H; Fang S; Qiu Y
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Old and New Paradigms of G1/S Control.
    Rubin SM; Sage J; Skotheim JM
    Mol Cell; 2020 Oct; 80(2):183-192. PubMed ID: 32946743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product.
    Elangovan S; Hsieh TC; Wu JM
    Anticancer Res; 2008; 28(5A):2641-7. PubMed ID: 19035289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the p16/cyclin D1/CDK4/Rb/E2F1 pathway on aberrant lung fibroblast proliferation in neonatal rats exposed to hyperoxia.
    Zhao S; Chen Z; Han S; Wu H
    Exp Ther Med; 2021 Oct; 22(4):1057. PubMed ID: 34434271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.